InvestorsHub Logo
Followers 57
Posts 5697
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Friday, 12/09/2016 12:26:36 PM

Friday, December 09, 2016 12:26:36 PM

Post# of 6033
The Austrian presentation announced that they are already manufacturing HS-120... the ComPACT version of HS-110 for NSCLC. And the last Conference Call announced that "soon" or "very soon" ComPACT will be in the clinic. This technology adds a powerful co-stimulator without adding toxicity.

I expect they will add several multi-combination arms to the DURGA trial. It was set up to have multiple arms. HS-110 has shown itself to be safe and produced a significant immune response. HS-120 and future combinations are expected to be equally safe and several times as powerful. Have alook at the great preclinical results of the ComPACT technology.

ComPACT video, poster and presentation.

http://www.heatbio.com/our-science/compact

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHWK News